Trainings and Resources

It is important to note The Standards outline a minimum standard of physician performance and should not be construed as describing the extent to totality of care that a person with addiction might require. Additionally, these standards are not substance-, behavior-, or setting-specific, but apply generally to the treatment of individuals with addiction involving any addictive substance or behavior in any medical setting.

In January 2014, the American Society of Addiction Medicine (ASAM) released its Standards of Care for the Addiction Specialist Physician.

The Addiction Severity Index (ASI) is a semi-structured interview designed to address seven potential problem areas in substance-abusing patients.

The CIWA-Ar assessment for monitoring withdrawal symptoms requires approximately 5 minutes to administer. The maximum score is 67. Patients scoring less than 10 do not usually need additional medication for withdrawal.

To identify Finnegan Neonatal Abstinence Scoring Tool tems independently associated with the decision to use pharmacologic therapy and to simplify the FNAST while minimizing loss of information for the treatment decision.

The Opioid Use Disorder, Pregnant Women and Neonatal Abstinence Syndrome (NAS): Addressing the Challenges (Part II) webinar took place on June 9, 2020.

Mother & Baby Substance Exposure Toolkit Best Practices All Best Practices came as a part of the California Medication Assisted Treatment Expansion Project

The Clinical Opiate Withdrawal Scale is an 11-item scale designed to be administered by a clinician.

The nation’s opioid epidemic continues to compromise the health and well-being of individuals, families, and communities. Federal policymakers and agencies are developing, implementing, and funding strategies focused on turning the tide to address opioid misuse, opioid use disorder, fatal and non-fatal drug overdoses, prenatal substance exposure, dissolution or breakup of families, and financial ruin experienced in communities nationwide.